Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 1 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AZ18
Term | Name | Level | Count |
---|---|---|---|
GO:0006417 | regulation of translation | 6 | 1 |
GO:0006449 | regulation of translational termination | 6 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009889 | regulation of biosynthetic process | 4 | 1 |
GO:0009891 | positive regulation of biosynthetic process | 5 | 1 |
GO:0009892 | negative regulation of metabolic process | 4 | 1 |
GO:0009893 | positive regulation of metabolic process | 4 | 1 |
GO:0010468 | regulation of gene expression | 5 | 1 |
GO:0010556 | regulation of macromolecule biosynthetic process | 5 | 1 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 6 | 1 |
GO:0010604 | positive regulation of macromolecule metabolic process | 5 | 1 |
GO:0010605 | negative regulation of macromolecule metabolic process | 5 | 1 |
GO:0010608 | post-transcriptional regulation of gene expression | 6 | 1 |
GO:0010628 | positive regulation of gene expression | 6 | 1 |
GO:0010629 | negative regulation of gene expression | 6 | 1 |
GO:0018126 | protein hydroxylation | 5 | 1 |
GO:0019222 | regulation of metabolic process | 3 | 1 |
GO:0019538 | protein metabolic process | 3 | 1 |
GO:0031323 | regulation of cellular metabolic process | 4 | 1 |
GO:0031325 | positive regulation of cellular metabolic process | 5 | 1 |
GO:0031326 | regulation of cellular biosynthetic process | 5 | 1 |
GO:0031328 | positive regulation of cellular biosynthetic process | 6 | 1 |
GO:0034248 | regulation of amide metabolic process | 5 | 1 |
GO:0034250 | positive regulation of amide metabolic process | 6 | 1 |
GO:0036211 | protein modification process | 4 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043243 | positive regulation of protein-containing complex disassembly | 6 | 1 |
GO:0043244 | regulation of protein-containing complex disassembly | 5 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0045727 | positive regulation of translation | 7 | 1 |
GO:0045905 | positive regulation of translational termination | 7 | 1 |
GO:0048518 | positive regulation of biological process | 3 | 1 |
GO:0048519 | negative regulation of biological process | 3 | 1 |
GO:0048522 | positive regulation of cellular process | 4 | 1 |
GO:0050789 | regulation of biological process | 2 | 1 |
GO:0050794 | regulation of cellular process | 3 | 1 |
GO:0051128 | regulation of cellular component organization | 4 | 1 |
GO:0051130 | positive regulation of cellular component organization | 5 | 1 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 1 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 5 | 1 |
GO:0051246 | regulation of protein metabolic process | 5 | 1 |
GO:0051247 | positive regulation of protein metabolic process | 6 | 1 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0080090 | regulation of primary metabolic process | 4 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
GO:2000112 | obsolete regulation of cellular macromolecule biosynthetic process | 6 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0003677 | DNA binding | 4 | 1 |
GO:0003824 | catalytic activity | 1 | 1 |
GO:0005488 | binding | 1 | 1 |
GO:0016491 | oxidoreductase activity | 2 | 1 |
GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 3 | 1 |
GO:0016706 | 2-oxoglutarate-dependent dioxygenase activity | 4 | 1 |
GO:0043565 | sequence-specific DNA binding | 5 | 1 |
GO:0051213 | dioxygenase activity | 3 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 174 | 178 | PF00656 | 0.524 |
CLV_C14_Caspase3-7 | 189 | 193 | PF00656 | 0.357 |
CLV_C14_Caspase3-7 | 403 | 407 | PF00656 | 0.310 |
CLV_C14_Caspase3-7 | 442 | 446 | PF00656 | 0.508 |
CLV_NRD_NRD_1 | 411 | 413 | PF00675 | 0.372 |
CLV_NRD_NRD_1 | 47 | 49 | PF00675 | 0.399 |
CLV_NRD_NRD_1 | 89 | 91 | PF00675 | 0.601 |
CLV_PCSK_KEX2_1 | 411 | 413 | PF00082 | 0.372 |
CLV_PCSK_KEX2_1 | 46 | 48 | PF00082 | 0.462 |
CLV_PCSK_KEX2_1 | 479 | 481 | PF00082 | 0.577 |
CLV_PCSK_KEX2_1 | 89 | 91 | PF00082 | 0.601 |
CLV_PCSK_PC1ET2_1 | 46 | 48 | PF00082 | 0.456 |
CLV_PCSK_PC1ET2_1 | 479 | 481 | PF00082 | 0.577 |
CLV_PCSK_SKI1_1 | 377 | 381 | PF00082 | 0.330 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.427 |
DEG_SPOP_SBC_1 | 117 | 121 | PF00917 | 0.400 |
DEG_SPOP_SBC_1 | 153 | 157 | PF00917 | 0.489 |
DEG_SPOP_SBC_1 | 68 | 72 | PF00917 | 0.355 |
DOC_CDC14_PxL_1 | 307 | 315 | PF14671 | 0.413 |
DOC_CKS1_1 | 283 | 288 | PF01111 | 0.503 |
DOC_CYCLIN_RxL_1 | 102 | 110 | PF00134 | 0.493 |
DOC_PP2B_PxIxI_1 | 286 | 292 | PF00149 | 0.436 |
DOC_PP4_FxxP_1 | 283 | 286 | PF00568 | 0.512 |
DOC_USP7_MATH_1 | 143 | 147 | PF00917 | 0.403 |
DOC_USP7_MATH_1 | 153 | 157 | PF00917 | 0.537 |
DOC_USP7_MATH_1 | 158 | 162 | PF00917 | 0.465 |
DOC_USP7_MATH_1 | 237 | 241 | PF00917 | 0.467 |
DOC_USP7_MATH_1 | 347 | 351 | PF00917 | 0.662 |
DOC_USP7_MATH_1 | 68 | 72 | PF00917 | 0.548 |
DOC_WW_Pin1_4 | 123 | 128 | PF00397 | 0.620 |
DOC_WW_Pin1_4 | 206 | 211 | PF00397 | 0.611 |
DOC_WW_Pin1_4 | 239 | 244 | PF00397 | 0.415 |
DOC_WW_Pin1_4 | 282 | 287 | PF00397 | 0.503 |
LIG_14-3-3_CanoR_1 | 387 | 395 | PF00244 | 0.382 |
LIG_BIR_III_4 | 33 | 37 | PF00653 | 0.344 |
LIG_BRCT_BRCA1_1 | 252 | 256 | PF00533 | 0.512 |
LIG_CSL_BTD_1 | 127 | 130 | PF09270 | 0.329 |
LIG_DCNL_PONY_1 | 1 | 4 | PF03556 | 0.419 |
LIG_deltaCOP1_diTrp_1 | 189 | 194 | PF00928 | 0.308 |
LIG_deltaCOP1_diTrp_1 | 261 | 266 | PF00928 | 0.421 |
LIG_eIF4E_1 | 274 | 280 | PF01652 | 0.517 |
LIG_FHA_1 | 320 | 326 | PF00498 | 0.576 |
LIG_FHA_1 | 358 | 364 | PF00498 | 0.327 |
LIG_FHA_1 | 428 | 434 | PF00498 | 0.490 |
LIG_FHA_1 | 70 | 76 | PF00498 | 0.622 |
LIG_FHA_1 | 8 | 14 | PF00498 | 0.463 |
LIG_FHA_2 | 172 | 178 | PF00498 | 0.356 |
LIG_FHA_2 | 283 | 289 | PF00498 | 0.455 |
LIG_FHA_2 | 75 | 81 | PF00498 | 0.544 |
LIG_FHA_2 | 94 | 100 | PF00498 | 0.639 |
LIG_LIR_Apic_2 | 177 | 183 | PF02991 | 0.365 |
LIG_LIR_Apic_2 | 261 | 267 | PF02991 | 0.421 |
LIG_LIR_Gen_1 | 229 | 238 | PF02991 | 0.247 |
LIG_LIR_Gen_1 | 425 | 433 | PF02991 | 0.445 |
LIG_LIR_Gen_1 | 470 | 476 | PF02991 | 0.492 |
LIG_LIR_Gen_1 | 76 | 85 | PF02991 | 0.431 |
LIG_LIR_Gen_1 | 8 | 19 | PF02991 | 0.291 |
LIG_LIR_Nem_3 | 240 | 244 | PF02991 | 0.432 |
LIG_LIR_Nem_3 | 247 | 252 | PF02991 | 0.476 |
LIG_LIR_Nem_3 | 324 | 329 | PF02991 | 0.432 |
LIG_LIR_Nem_3 | 407 | 413 | PF02991 | 0.452 |
LIG_LIR_Nem_3 | 470 | 475 | PF02991 | 0.490 |
LIG_LIR_Nem_3 | 8 | 14 | PF02991 | 0.318 |
LIG_Pex14_1 | 190 | 194 | PF04695 | 0.307 |
LIG_Pex14_1 | 369 | 373 | PF04695 | 0.429 |
LIG_SH2_CRK | 180 | 184 | PF00017 | 0.354 |
LIG_SH2_CRK | 234 | 238 | PF00017 | 0.470 |
LIG_SH2_CRK | 315 | 319 | PF00017 | 0.477 |
LIG_SH2_STAP1 | 252 | 256 | PF00017 | 0.421 |
LIG_SH2_STAP1 | 472 | 476 | PF00017 | 0.491 |
LIG_SH2_STAT5 | 134 | 137 | PF00017 | 0.291 |
LIG_SH2_STAT5 | 274 | 277 | PF00017 | 0.464 |
LIG_SH3_3 | 124 | 130 | PF00018 | 0.417 |
LIG_SH3_3 | 18 | 24 | PF00018 | 0.317 |
LIG_SH3_3 | 298 | 304 | PF00018 | 0.413 |
LIG_SH3_3 | 305 | 311 | PF00018 | 0.412 |
LIG_SH3_3 | 62 | 68 | PF00018 | 0.454 |
LIG_SUMO_SIM_anti_2 | 396 | 404 | PF11976 | 0.409 |
LIG_SUMO_SIM_par_1 | 358 | 364 | PF11976 | 0.278 |
LIG_TRAF2_1 | 85 | 88 | PF00917 | 0.519 |
LIG_TYR_ITIM | 313 | 318 | PF00017 | 0.251 |
LIG_WRC_WIRS_1 | 191 | 196 | PF05994 | 0.380 |
MOD_CK1_1 | 115 | 121 | PF00069 | 0.460 |
MOD_CK1_1 | 157 | 163 | PF00069 | 0.533 |
MOD_CK1_1 | 391 | 397 | PF00069 | 0.464 |
MOD_CK1_1 | 425 | 431 | PF00069 | 0.395 |
MOD_GlcNHglycan | 120 | 123 | PF01048 | 0.548 |
MOD_GlcNHglycan | 156 | 159 | PF01048 | 0.564 |
MOD_GlcNHglycan | 171 | 174 | PF01048 | 0.455 |
MOD_GlcNHglycan | 216 | 220 | PF01048 | 0.510 |
MOD_GlcNHglycan | 33 | 37 | PF01048 | 0.438 |
MOD_GlcNHglycan | 349 | 352 | PF01048 | 0.653 |
MOD_GlcNHglycan | 357 | 360 | PF01048 | 0.541 |
MOD_GlcNHglycan | 406 | 409 | PF01048 | 0.525 |
MOD_GlcNHglycan | 441 | 444 | PF01048 | 0.453 |
MOD_GlcNHglycan | 451 | 457 | PF01048 | 0.469 |
MOD_GlcNHglycan | 82 | 85 | PF01048 | 0.532 |
MOD_GSK3_1 | 112 | 119 | PF00069 | 0.462 |
MOD_GSK3_1 | 143 | 150 | PF00069 | 0.364 |
MOD_GSK3_1 | 153 | 160 | PF00069 | 0.414 |
MOD_GSK3_1 | 248 | 255 | PF00069 | 0.281 |
MOD_GSK3_1 | 355 | 362 | PF00069 | 0.488 |
MOD_GSK3_1 | 387 | 394 | PF00069 | 0.412 |
MOD_GSK3_1 | 69 | 76 | PF00069 | 0.518 |
MOD_N-GLC_1 | 319 | 324 | PF02516 | 0.353 |
MOD_N-GLC_1 | 419 | 424 | PF02516 | 0.477 |
MOD_N-GLC_2 | 257 | 259 | PF02516 | 0.281 |
MOD_N-GLC_2 | 29 | 31 | PF02516 | 0.447 |
MOD_N-GLC_2 | 368 | 370 | PF02516 | 0.282 |
MOD_NEK2_1 | 144 | 149 | PF00069 | 0.436 |
MOD_NEK2_1 | 357 | 362 | PF00069 | 0.496 |
MOD_NEK2_1 | 4 | 9 | PF00069 | 0.471 |
MOD_NEK2_2 | 427 | 432 | PF00069 | 0.309 |
MOD_PIKK_1 | 57 | 63 | PF00454 | 0.427 |
MOD_PKA_2 | 169 | 175 | PF00069 | 0.488 |
MOD_PKA_2 | 404 | 410 | PF00069 | 0.457 |
MOD_Plk_1 | 422 | 428 | PF00069 | 0.378 |
MOD_ProDKin_1 | 123 | 129 | PF00069 | 0.611 |
MOD_ProDKin_1 | 206 | 212 | PF00069 | 0.611 |
MOD_ProDKin_1 | 239 | 245 | PF00069 | 0.253 |
MOD_ProDKin_1 | 282 | 288 | PF00069 | 0.377 |
MOD_SUMO_rev_2 | 471 | 481 | PF00179 | 0.350 |
TRG_DiLeu_BaEn_1 | 396 | 401 | PF01217 | 0.511 |
TRG_DiLeu_BaEn_1 | 471 | 476 | PF01217 | 0.374 |
TRG_ENDOCYTIC_2 | 11 | 14 | PF00928 | 0.410 |
TRG_ENDOCYTIC_2 | 315 | 318 | PF00928 | 0.341 |
TRG_ENDOCYTIC_2 | 472 | 475 | PF00928 | 0.489 |
TRG_ER_diArg_1 | 410 | 412 | PF00400 | 0.363 |
TRG_ER_diArg_1 | 47 | 49 | PF00400 | 0.457 |
TRG_NES_CRM1_1 | 288 | 298 | PF08389 | 0.390 |
TRG_Pf-PMV_PEXEL_1 | 184 | 189 | PF00026 | 0.369 |
TRG_Pf-PMV_PEXEL_1 | 56 | 61 | PF00026 | 0.351 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I519 | Leptomonas seymouri | 50% | 92% |
A0A0S4JI40 | Bodo saltans | 30% | 98% |
A0A1X0P4A9 | Trypanosomatidae | 38% | 100% |
A0A3R7LP24 | Trypanosoma rangeli | 40% | 100% |
A0A3S7X0M0 | Leishmania donovani | 88% | 99% |
A4HFP0 | Leishmania braziliensis | 76% | 100% |
A4I2R6 | Leishmania infantum | 88% | 99% |
D0A5X2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 36% | 100% |
E9AD93 | Leishmania major | 90% | 100% |
Q08BY5 | Danio rerio | 27% | 100% |
V5BD54 | Trypanosoma cruzi | 40% | 100% |